José E. Navarrete

405 citations
17 papers · 278 indexed · h-index 7

José E. Navarrete

14 papers receiving 271 citations

Peers

José E. Navarrete
Comparison fields: 5 of 50
  • Genetics 174
  • Hematology 151
  • Nephrology 39
  • Obstetrics and Gynecology 14
  • Endocrinology, Diabetes and Metabolism 24
Replace Edip Gali with:
Edip Gali Türkiye
Sevgi Gurkan United States
Fotis Papachristou Greece
Alessia Marcon Italy
Christophe Bovy Belgium
Omar Niss United States
Khawla Belhoul United Arab Emirates
P. Saidi United States
Keiji Fujimoto Japan
Fotis Karabatsos Greece
José E. Navarrete relative to Edip Gali Türkiye Edip Gali's profile →
Citations per field
00.5×5.7×
Edip Gali · 1×
Citations per year

Countries citing papers authored by José E. Navarrete

Since Specialization
Citations

This map shows the geographic impact of José E. Navarrete's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José E. Navarrete with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José E. Navarrete more than expected).

Fields of papers citing papers by José E. Navarrete

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José E. Navarrete. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José E. Navarrete. The network helps show where José E. Navarrete may publish in the future.

Co-authorship network

The 25 scholars most cited alongside José E. Navarrete, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with José E. Navarrete Line = papers co-authored together José E. Navarrete links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20250
2 202310
3 20236
4 202310
5 20230
6 20226
7 20222
8 20217
9 202114
10 20210
11 20215
12 20203
13 202027
14 20192
15 20168
16 2006174
17
Effect of highly active antiretroviral treatment and prednisone in biopsy-proven HIV-associated nephropathy
20004

About José E. Navarrete

José E. Navarrete is a scholar working on Nephrology, Hematology and Modeling and Simulation, having authored 17 papers that have together received 278 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), COVID-19 and healthcare impacts (3 papers), Renal function and acid-base balance (2 papers), Iron Metabolism and Disorders (2 papers), Renal Diseases and Glomerulopathies (2 papers), Dialysis and Renal Disease Management (2 papers), Diabetes Treatment and Management (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). The work is most often cited by research in Genetics (174 citations), Hematology (151 citations) and Nephrology (39 citations). José E. Navarrete has collaborated with scholars based in United States, Chile and Australia. Frequent co-authors include Carlos Zayas, Antonio Guasch, W. Charles O’Neill, Gurleen Kaur, Janice P. Lea, Juan Carlos Q. Velez, Stephen O. Pastan, Fuad El Rassi, Laura Plantinga and Frederic F. Rahbari-Oskoui. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026